CGM Expansion Wellstart recently launched Dexcom G7 15-day CGM through Wellstart Medical, LLC, signaling an expanded product capability in glucose monitoring that can be paired with diabetes supply purchases for recurring revenue.

Recurring Diabetes Supplies The company focuses on a fast, simple, and reliable way to purchase diabetes supplies on a recurring basis, presenting a strong cross-sell opportunity to expand customers’ recurring order volumes and lifecycle value.

Mid-Market Scale With 51-200 employees and revenue in the $10M–$25M range, Wellstart occupies a mid-market niche that aligns well with distributors and healthcare providers seeking scalable partnerships and co-sell opportunities.

Tech-Enabled Ops Utilizes iCIMS, Salesforce, Wix eCommerce, Google Cloud and Box, indicating a modernized tech stack that can streamline contract management, account-based sales, and eCommerce fulfillment for new partner integrations.

Healthcare Alignment Positioned in wellness and diabetes care education and access, presenting cross-sell potential with large healthcare distributors and medical supply chains aiming to expand digital health adoption and patient support programs.